Prolife Industries Board of Directors

Get the latest insights into the leadership at Prolife Industries. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Karan M Jolly Managing Director
Mrs. Anureet Kaur Jolly Director
Mr. Siddharth Raghuvanshi Director
Mr. Veljibhai K Patel Director
Mr. Dharmendra Pushkarna Independent Director
Mr. Keshavkumar B Singh Independent Director

Prolife Industries Share price

PROLIFE

131

0.00 (0.00%)
NSE
BSE
Last updated on 4 Sep, 2025 | 09:07 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

124.50

52 Week High

361.00

The current prices are delayed, login to your account for live prices

Prolife Industries FAQs

The board at Prolife Industries consists of experienced professionals, including Mr. Karan M Jolly , Mrs. Anureet Kaur Jolly , and others, overseeing the company’s strategic and corporate governance.

Directors at Prolife Industries are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Karan M Jolly is the current chairman at Prolife Industries.

Executive directors at Prolife Industries are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Prolife Industries adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Prolife Industries, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.